09May/13

Jeff Hanneman Dies of Liver Failure Contributed to Spider Bite – Cashbox Magazine Canada


Billboard

Jeff Hanneman Dies of Liver Failure Contributed to Spider Bite
Cashbox Magazine Canada
On Thursday, May 2, 2013, Slayer guitarist Jeff Hanneman passed away from liver failure in a Los Angeles hospital. In what was a bizarre set of circumstances, the theory was that a bite from a spider over two years ago might have contributed to his death.
Doctor: Spider Bite Not To Blame For Hanneman’s DeathGun Shy Assassin
Slayer: Guitarist died of alcohol-related cirrhosisDetroit Free Press
‘Raining Blooderator’ pays tribute to late Slayer guitaristRegister
Charleston City Paper –The Gauntlet –Stereoboard.com
all 13 news articles »
09May/13

Rejuvenating hormone found to reverse symptoms of heart failure – Science Daily – Science Daily (press release)


Medical Daily

Rejuvenating hormone found to reverse symptoms of heart failure – Science Daily
Science Daily (press release)
May 9, 2013 — Heart failure is one of the most debilitating conditions linked to old age, and there are no specific therapies for the most common form of this condition in the elderly. A study published by Cell Press May 9th in the journal Cell
Mouse blood swap reverses age-related heart failure – USA TodayUSA TODAY
Blood ‘Youth’ Hormone Reverses Aging in Mouse HeartsMedical Daily
Growth Hormone That Can Reverse Age-Related Heart Failure? Scientists Swap Latinos Post
Harvard Magazine –Daily Mail –Boston Globe
all 20 news articles »
09May/13

Treven And Forest Labs Reach Deal To Develop TRV027 To Treat Acute Heart … – RTT News

Treven And Forest Labs Reach Deal To Develop TRV027 To Treat Acute Heart
RTT News
Trevena said TRV027 is an experimental intravenous drug for the treatment of acute decompensated heart failure (ADHF), currently in mid-stage clinical trials. It is a novel beta-arrestin biased ligand of the angiotensin II type 1 receptor (AT1R) that
Forest Labs Bets Up To $460M on Trevena Heart Failure DrugGenetic Engineering News
Trevena Raises $60M Series C, Strikes $430M Option Deal With Forest LabsDow Jones Bankruptcy & Debt (registration)
Trevena lands $430M Forest deal, $60M venture round as heart drug heads to FierceBiotech

all 5 news articles »